Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

BINUS SCHOOL Simprug Announces Students' Participation in an International Scientific Publication about COVID-19

JAKARTA, Indonesia, Dec. 16, 2021 /PRNewswire/ -- BINUS SCHOOL Simprug, an International Baccalaureate (IB)World School in Indonesia, announces that 15 of their high school students have participated in the creation of a scientific journal titledVoice Processing for COVID-19 Scanning and Progn...

2021-12-16 17:02 2022

BINUS SCHOOL Simprug Announces Students' Participation in an International Scientific Publication about COVID-19

SenseTime Partners with Macau's Kiang Wu Hospital to Advance Smart Health Application with AI

MACAU, Dec. 16, 2021 /PRNewswire/ -- SenseTime, a leading global artificial intelligence (AI) software company, has formed a strategic partnership with Kiang Wu Hospital, one of the largest and oldest hospitals inMacau to advance smart health application and research with AI.

2021-12-16 16:58 2192

SenseTime Partners with Macau's Kiang Wu Hospital to Advance Smart Health Application with AI

Antengene and XtalPi Announce AI-Driven R&D Collaboration

SHANGHAI and HONG KONG, Dec. 16, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and other life...

2021-12-16 16:30 2724

BioWorld by Clarivate Identifies the Top Six Global Biopharmaceutical Stories and Trends of 2021

Advances in Alzheimer's, innovation in DNA vaccines, increased regulatory collaboration and the evolving impact of Artificial Intelligence, join Covid-19 as key stories and trends of 2021 LONDON, Dec. 16, 2021 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a global leader in pr...

2021-12-16 16:14 2077

Debiopharm Further Explores the Potential of its Potent, Highly Selective WEE1 Inhibitor Debio 0123 In Phase 1 Cancer Study

Dose escalation, monotherapy trial launched to access the safety and preliminary anti-tumor activity of Debio 0123 in the treatment of advanced solid tumors LAUSANNE, Switzerland, Dec. 16, 2021 /PRNewswire/ -- Debiopharm ( www.debiopharm.com ), a Swiss biopharmaceutica...

2021-12-16 16:00 1736

PHASE 3 TRIAL OF SHR8058 EYE DROPS (PERFLUOROHEXYLOCTANE) CONDUCTED BY JIANGSU HENGRUI PHARMACEUTICALS IN THE PEOPLE'S REPUBLIC OF CHINA SHOWS STATISTICALLY SIGNIFICANT TOPLINE RESULTS

HEIDELBERG, Germany, and CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today provided a development update on the phase 3 trial of SHR8058 eye drops ...

2021-12-16 15:00 1282

French Neurosurgeon and Physicist Dr. Alim Louis Benabid, Recipient of 42nd Honda Prize, Honored at Online Award Ceremony

TOKYO, Dec. 16, 2021 /PRNewswire/ -- The Honda Foundation, based in Tokyo, is pleased to announce that the 42nd Honda Prize Award Ceremony was held on Wednesday, November 17, 2021, and awarded this year's prize to Dr. Alim Louis Benabid, emeritus professor at the Joseph Fourier University and chai...

2021-12-16 15:00 1181

LifeTech and Medtronic Further Strategic Collaboration to Open New Chapter of Domestically-Made MRI-Conditional Pacemakers

SHENZHEN, China, Dec. 16, 2021 /PRNewswire/ -- LifeTech Scientific Corporation (LifeTech, 01302.HK) announced that it has extended its agreements with Medtronic to further the strategic collaboration on the "HeartTone™ domestic pacemaker project" and to start the collaboration on domestically-mad...

2021-12-16 12:41 2971

Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine

-- Takeda submits application for TAK-019/NVX-CoV2373, the first protein-based COVID-19 vaccine candidate for NDA, toJapan's Ministry of Health, Labour and Welfare (MHLW) -- Interim data from Phase 1/2 trial in Japan demonstrate robust immune response and favorable tolerability with no serious a...

2021-12-16 12:03 1994

The Clinician begins rollout of patient-reported outcome and experience measures for the Singapore public healthcare system

SINGAPORE, Dec. 16, 2021 /PRNewswire/ -- The Clinician , a global digital health leader, has partnered with Singapore's HealthTech agency, Integrated Health Information Systems (IHiS), to launch an electronic patient-reported outcome and experience measures (PROMs and ...

2021-12-16 10:20 3021

Prenetics Launches Circle Healthpod At Hong Kong International Airport, Providing Travellers With Rapid COVID-19 PCR Quality Results In Less Than 60 Minutes

* Results Available In the Form of Digital Health Passport, SMS and Email * HealthPod Results Accepted by 13 Countries as Valid Pre-Departure COVID-19 Test:USA, Canada, UK, Spain, Germany, Italy, Netherlands, Sweden, Luxembourg, New Zealand, South Korea and more * Circle HealthPod, with Te...

2021-12-16 09:00 2822

Everest Medicines announces FDA grants our Partner Calliditas Therapeutics Accelerated Approval of TARPEYO™ (budesonide) to Reduce Proteinuria in IgA Nephropathy

* TARPEYO (budesonide) delayed release capsules is the first and only treatment indicated to reduce proteinuria in adults withprimary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) ≥1.5g/g1 * TARPEYO (developed un...

2021-12-16 08:49 2481

Statement by WuXi AppTec Regarding Recent Market Fluctuation

SHANGHAI, Dec. 15, 2021 /PRNewswire/ -- Our company's activities continue apace and we remain confident in our platform, which enables our global customers and serves patients around the world. We will provide any new information as warranted and in compliance with applicable laws and regulations...

2021-12-16 08:00 2293

AUSTRALIAN LIFE SCIENCE COMPANY, QBIOTICS, LAUNCHES STELFONTA® ITS LEAD VETERINARY PHARMACEUTICAL IN AUSTRALIA, FOLLOWING LAUNCHES IN OTHER KEY GLOBAL MARKETS

* QBiotics commences the Australian commercial launch of its lead veterinary drug, STELFONTA®, which is approved by the Australian Pesticides and Veterinary Medicines Authority (APVMA) for the treatment of canine non-metastatic mast cell tumours (MCT) * The Australian launch is a significant ...

2021-12-16 03:58 2042

AUSTRALIAN LIFE SCIENCE COMPANY, QBIOTICS, LAUNCHES STELFONTA® ITS LEAD VETERINARY PHARMACEUTICAL IN AUSTRALIA, FOLLOWING LAUNCHES IN OTHER KEY GLOBAL MARKETS

SQREEM's New AI-powered Study Examines Motivations Surrounding COVID-19 Vaccine Resistance in the US

NEW YORK, Dec. 15, 2021 /PRNewswire/ -- COVID-19 vaccines have once again become a hot topic inthe United States as President Joe Biden pushes on with vaccination mandates in a bid to manage concerns around the Omicron variant ahead of the winter flu season. Despite vaccination ratesreaching 60%...

2021-12-15 22:00 1369

SQREEM's New AI-powered Study Examines Motivations Surrounding COVID-19 Vaccine Resistance in the US

CSafe Global Announces Acquisition of Softbox Systems to Create the Global Leader in Temperature-Controlled Shipping Solutions

DAYTON, Ohio and LONG CRENDON, Buckinghamshire, England, Dec. 15, 2021 /PRNewswire/ --CSafe Global, the leader in temperature-controlled container solutions for the pharmaceutical industry, announced today that it has acquired Softbox Systems, a provider of passive temperature-controlled packaging...

2021-12-15 22:00 2587

Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine

NEW BRUNSWICK, N.J., Dec. 15, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a Positive Opinion for use of the Company's COVID-19 vaccine as a booster for...

2021-12-15 21:58 2144

FDA Breakthrough Devices Designation Application to Fast-Track Painful Finger-Prick Alternative for People Living with Diabetes

SYDNEY, Dec. 15, 2021 /PRNewswire/ -- Life Science Biosensor Diagnostics Pty Ltd (LSBD), a life sciences and medical technology company and subsidiary of The iQ Group Global, announced it has filed an application with the U.S Food and Drug Administration (FDA) for Breakthrough Devices Designation...

2021-12-15 21:01 1205

I-Mab Receives IND Approval for Phase 1 Clinical Trial of Bispecific Antibody TJ-CD4B in Solid Tumors in China

SHANGHAI and GAITHERSBURG, Md., Dec. 15, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the Center for Drug Evaluation (CDE) ofChina's Na...

2021-12-15 21:00 1300

BenevolentAI achieves second major collaboration milestone with novel idiopathic pulmonary fibrosis target selected for AstraZeneca's portfolio

- Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's AI-drug discovery platform and experimentally validated by AstraZeneca - Announcement represents the second collaboration milestone following the addition of a novel chronic kidney disease target to AstraZeneca'...

2021-12-15 16:00 1164

1 ... 302 303 304305306 307 308 ... 578